Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Vanda Pharmaceuticals Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 178 | 188 | +10 |
| Shares | 58.2M | 56.2M | −1.99M (−3.4%) |
| Value | $395.9M | $370.7M | −$25.2M (−6.4%) |
New holders (21)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hillsdale Investment Management Inc. | 232,642 | $1.53M | 0.14% |
| Wellington Management Group LLP | 208,389 | $1.37M | 0.00% |
| Empowered Funds, LLC | 155,375 | $1.02M | 0.04% |
| EA Series Trust | 155,375 | $1.02M | 0.04% |
| Allianz Asset Management GmbH | 97,400 | $641.9K | 0.00% |
| ExodusPoint Capital Management, LP | 73,822 | $486.0K | 0.01% |
| Squarepoint Ops LLC | 65,537 | $431.9K | 0.00% |
| Campbell & CO Investment Adviser LLC | 45,011 | $296.6K | 0.05% |
| Jane Street Group, LLC | 42,793 | $282.0K | 0.00% |
| Dark Forest Capital Management LP | 33,665 | $221.9K | 0.02% |
| Cornercap Investment Counsel Inc | 33,003 | $217.5K | 0.04% |
| Fox Run Management, L.L.C. | 21,890 | $144.3K | 0.04% |
| Xponance, Inc. | 17,819 | $117.4K | 0.00% |
| Axq Capital, LP | 12,713 | $83.8K | 0.10% |
| HighTower Advisors, LLC | 12,263 | $80.0K | 0.00% |
| Banque Cantonale Vaudoise | 10,783 | $71.0K | 0.00% |
| Balyasny Asset Management LLC | 10,289 | $67.8K | 0.00% |
| Massmutual Trust Co FSB | 1,009 | $6.65K | 0.00% |
| CGC Financial Services, LLC | 50 | $330 | 0.00% |
| Allworth Financial LP | 37 | $244 | 0.00% |
| Comerica Bank | 834 | $75 | 0.01% |
Sold out (11)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Epoch Investment Partners, Inc. | 706,570 | $4.80M |
| Tang Capital Management LLC | 100,000 | $679.0K |
| Easterly Investment Partners LLC | 60,557 | $411.2K |
| Y-Intercept (Hong Kong) Ltd | 42,743 | $290.2K |
| SG Americas Securities, LLC | 34,379 | $233.0K |
| HFR Wealth Management, LLC | 20,000 | $136.0K |
| Simplex Trading, LLC | 1,706 | $11.0K |
| Accel Wealth Management | 300 | $2.04K |
| Baker Avenue Asset Management, LP | 200 | $1.36K |
| International Assets Investment Management, LLC | 94 | $638 |
| Belpointe Asset Management LLC | 21 | $143 |